In addition, a large fraction of CRC tumors exhibit a constitutive activation of prominent pro-inflammatory signaling pathways, such as signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB (NF-κB) [14]. The gene discussed is NFKB1; the disease is colorectal carcinoma.